Back to all Programs

Register here

Related Materials

Past event

Tokyo Hepatitis Clinical Forum 2019

Trend of NAFLD/ NASH in Japan - Katsutoshi Tokushige, MD

Hepatitis C Management in Special Populations - Mark Nelson, MD

Challenges in the Era of Hepatitis C Cure - Naoya Sakamoto, MD

Management of Hepatitis B Reactivation - Yasuhito Tanaka, MD, PhD

New Anti-HBV Drugs in the Pipeline - Man-Fung Yuen, DSc, MD, PhD

Immunological Aspects of HBV and HCV Infection - Tatsuya Kanto, MD, PhD

Progress in Hepatitis B Cure Research - Peter Revill, MD, PhD

Current and Future Local Therapies for Early Stage HCC -Shi-Ming Lin, MD

Evolving Treatment Paradigm and Future Landscape in HCC - Masafumi Ikeda, MD